Our Company
Harnessing T Cells for precision diagnostics
T Cell Diagnostics Pte. Ltd. (TCD) is a Singapore-based biotechnology company established in 2021. We specialise in the precise measurement of virus-specific T cell responses—transforming cutting-edge immunological research into accessible, clinically relevant diagnostic tools.
Our mission is to bridge the gap between complex immunology and practical healthcare. We empower clinicians, researchers, and industry partners with innovative solutions to understand, monitor, and harness T cell immunity for improved diagnostics, disease management, and therapeutic development.

Our Services
Consultation
We provide scientific and technical guidance on immune monitoring, assay selection, and study design—tailored to support clinical research, therapeutic programs, and the implementation of diagnostics.
Custom Assays
Our team develops and validates bespoke T cell assays for specific pathogens or clinical needs. Our flexible platforms accommodate diverse sample types, including whole blood, PBMCs, and tissue-derived immune cells.
Data Analysis
We transform complex immunological data into clear, actionable insights—supporting high-resolution immune profiling for vaccine research, infection monitoring, and immunotherapy assessment.
Our Focus
TCD’s core expertise lies in virus-specific cellular immunity. We focus on T cell diagnostics for infectious diseases, including:

Coronaviridae

Hepadnaviridae

Paramyxoviridae

Orthomyxoviridae

Flaviviridae

Bunyaviridae

Herpesviridae
By measuring both the frequency and function of antigen-specific T cells, our diagnostics offer insights that extend beyond traditional antibody-based tests—essential for evaluating immune memory, vaccine efficacy, and therapeutic outcomes.
Located in Singapore’s Biopolis research hub, our BSL-2 laboratory is fully equipped for T cell diagnostics, cytokine release assays, and clinical sample processing. This central location allows us to serve partners locally, regionally, and globally with speed, flexibility, and precision.

TCD was co-founded by leading immunologists, including Professor Antonio Bertoletti, whose research at Duke-NUS laid the foundation for simplified T cell diagnostics. Our proprietary whole-blood cytokine release assay, developed in partnership with Duke-NUS, offers a minimally invasive and scalable solution for measuring T cell responses in clinical and point-of-care settings.
At T Cell Diagnostics, we are redefining how immune profiling informs precision medicine. T cells—once overlooked due to technical complexity—are now recognised as essential indicators of immune protection and disease progression.

Through licensed intellectual property and ongoing collaboration, we transform academic discoveries into real-world diagnostic platforms, supporting clinical trials, vaccine development, and immunotherapy monitoring worldwide.
By making T cell diagnostics accessible, reliable, and scalable, we are unlocking new frontiers in immunology—enabling better care, deeper insights, and a more personalised approach to healthcare.
